Consolidated Statement of Changes in Equity - USD ($) $ in Millions		Total		Common Stock, $0.10 Par Value	Capital In Excess of Par		Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Non-controlling Interest
Beginning balance at Dec. 31, 2014		$ 1,564.0		$ 18.6	$ 401.9		$ 2,984.5	$ (375.8)	$ (1,498.7)	$ 33.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income		498.5					489.0			9.5
Stock compensation plans		20.7			14.4				6.3
Excess tax benefits from share-based compensation		1.4			1.4
Shares for benefit plan trust, decrease		(2.2)							(2.2)
Net pension and other benefit actuarial gains/(losses) and prior service costs, net of income tax		17.7						17.7
Net hedging gains (losses) and other, net of income tax		(2.3)						(2.3)
Foreign currency translation adjustments		(97.3)	[1]					(96.9)		(0.4)
Dividends		(88.5)					(88.5)
Repurchases of common stock		(3.7)							(3.7)
Ending balance at Dec. 31, 2015		1,908.3		18.6	417.7		3,385.0	(457.3)	(1,498.3)	42.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income		211.7					209.1			2.6
Stock compensation plans		24.2			19.9				4.3
Excess tax benefits from share-based compensation		(0.4)			(0.4)
Shares for benefit plan trust, increase		0.4							0.4
Net pension and other benefit actuarial gains/(losses) and prior service costs, net of income tax		12.3						12.3
Net hedging gains (losses) and other, net of income tax		13.3						13.3
Foreign currency translation adjustments		(48.7)	[1]					(46.7)		(2.0)
Dividends		(88.6)					(88.6)
Repurchases of common stock		(13.0)							(13.0)
Transactions with noncontrolling interests, decrease		(26.5)	[2]		(18.6)	[2]				(7.9)
Ending balance at Dec. 31, 2016		1,993.0		18.6	418.6		3,505.5	(478.4)	(1,506.6)	35.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income		538.4					535.8			2.6
Stock compensation plans		42.6			33.0				9.6
Excess tax benefits from share-based compensation		2.9
Shares for benefit plan trust, decrease		(0.2)							(0.2)
Net pension and other benefit actuarial gains/(losses) and prior service costs, net of income tax		52.2						52.2
Net hedging gains (losses) and other, net of income tax		(1.9)						(1.9)
Foreign currency translation adjustments		186.6	[1]					187.8		(1.2)
Dividends		(88.9)					(88.9)
Repurchases of common stock		(2.4)							(2.4)
Noncontrolling interests associated with an acquisition	[2]	12.7								12.7
Transactions with noncontrolling interests, decrease		(25.0)	[2]		(0.9)	[2]				(24.1)
Ending balance at Dec. 31, 2017		$ 2,707.1		$ 18.6	$ 450.7		$ 3,952.4	$ (240.3)	$ (1,499.6)	$ 25.3

[1] Income taxes are not provided on the equity in undistributed earnings of our foreign subsidiaries or affiliates since it is our intention that such earnings will remain invested in those affiliates indefinitely. The amount for 2017 includes reclassification to net income due to the divestiture of our FMC Health and Nutrition segment which includes the portion of FMC Health and Nutrition sold to DuPont and the Omega-3 business sold to Pelagia AS. See Note 9 for more information. In accordance with accounting guidance, this amount was previously factored into the lower of cost or fair value test associated with the 2017 Omega-3 asset held for sale write-down charges.

[2] See Notes 3 and 15 for more detail on the acquisitions of noncontrolling interest and transactions with noncontrolling interest, respectively.